Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
207.4 EUR | -0.38% | +0.73% | -13.40% |
04-23 | SARTORIUS STEDIM BIOTECH : Barclays reaffirms its Neutral rating | ZD |
04-22 | Sartorius Stedim: in the red with brokerage comments | CF |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.40% | 21.84B | |
-3.54% | 185B | |
-0.58% | 109B | |
-2.74% | 68.54B | |
+4.84% | 51.74B | |
+10.40% | 45.22B | |
+3.12% | 41.74B | |
+2.87% | 26.69B | |
+4.61% | 26.83B | |
+11.62% | 25.63B |
- Stock Market
- Equities
- DIM Stock
- News Sartorius Stedim Biotech
- Transcript : Sartorius Stedim Biotech S.A., Q1 2024 Earnings Call, Apr 18, 2024